Mucosa-associated lymphoid tissue lymphoma (MALT)

Clinical trials for Mucosa-associated lymphoid tissue lymphoma (MALT) explained in plain language.

Never miss a new study

Get alerted when new Mucosa-associated lymphoid tissue lymphoma (MALT) trials appear

Sign up with your email to follow new studies for Mucosa-associated lymphoid tissue lymphoma (MALT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New drug duo aims to control rare lymphoma without chemotherapy

Disease control Ongoing

This study tests whether combining zanubrutinib (a targeted pill) with rituximab (an antibody infusion) can shrink or control MALT lymphoma, a slow-growing cancer of the lymph nodes and organs. About 42 adults with newly diagnosed advanced disease or lymphoma that returned after …

Matched conditions: MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA (MALT)

Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control

Last updated Sep 17, 2026 00:00 UTC

Mucosa-associated lymphoid tissue lymphoma (MALT)

Get alerted when new Mucosa-associated lymphoid tissue lymphoma (MALT) trials appear

New drug duo aims to control rare lymphoma without chemotherapy